Search Result "BRCA carrier"
What are the Cancer Risks in BRCA Carriers Apart from Those Regarding the Breast and the Ovary?
Journal: Current Women`s Health Reviews
Volume: 8 Issue: 1 Year: 2012 Page: 65-71
Author(s): F. Di Gaudio, V. Calo, L. La Paglia, L. Bruno, F. Di Piazza, N. Margarese, F. P. Guadagna, G. Guarneri, G. Cicero, G. R. Ricciardi, C. Rolfo Cervetto, G. Cucinella, G. Pantuso, V. Bazan, A. Russo
BRCA-FA Pathway as a Target for Anti-Tumor Drugs
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 8 Issue: 4 Year: 2008 Page: 426-430
Author(s): Rachel Litman, Rigu Gupta, Robert M. Brosh, Jr., Sharon B. Cantor
Presence of Intratumoral Stem Cells in Breast Cancer Patients with or without BRCA Germline Mutations
Journal: Current Cancer Drug Targets
Volume: 12 Issue: 1 Year: 2012 Page: 44-50
Author(s): C. F. Singer, P. Zabkova, C. Rappaport, D. Muhr, G. Pfeiler, D. Gschwantler-Kaulich, A. Fink-Retter, C. Staudigl, I. Walter, G. Hudelist, A.-C. Spiess, E. Kubista
Modifiers of Risk in BRCA1/2 Mutation Carriers
Journal: Current Women`s Health Reviews
Volume: 8 Issue: 1 Year: 2012 Page: 23-29
Author(s): Stefano Pepe, Matilde Pensabene, Caterina Condello
BRCA Unclassified Variants: How Can They be Classified?
Journal: Current Women`s Health Reviews
Volume: 8 Issue: 1 Year: 2012 Page: 30-37
Author(s): Stefania Tommasi, Simona De Summa, Brunella Pilato, Angelo Paradiso
BRCA Mutational Status is a Promising Predictive Biomarker for Platinum- based Chemotherapy in Triple-Negative Breast Cancer
Journal: Current Drug Targets
Volume: 21 Issue: 10 Year: 2020 Page: 962-973
Author(s): Amal Tazzite,Hassan Jouhadi,Abdellatif Benider,Sellama Nadifi
Parp Inhibitors for the Treatment of Ovarian Cancer
Journal: Current Cancer Drug Targets
Volume: 18 Issue: 9 Year: 2018 Page: 877-893
Author(s): Laura Cortesi,Angela Toss,Iole Cucinotto
Inducing Synthetic Lethality using PARP Inhibitors
Journal: Current Clinical Pharmacology
Volume: 5 Issue: 3 Year: 2010 Page: 192-195
Author(s): David S. Boss, Jos H. Beijnen, Jan H.M. Schellens
The Role of PARP Inhibitors in the Treatment of Ovarian Carcinomas
Journal: Current Pharmaceutical Design
Volume: 18 Issue: 25 Year: 2012 Page: 3770-3774
Author(s): Anna V. Tinker,Karen Gelmon
Triple-negative Breast Cancer and Poly(ADP-ribose) Polymerase Inhibitors
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 12 Issue: 6 Year: 2012 Page: 672-677
Author(s): Youngjin Park,Ayako Moriyama,Tomoaki Kitahara,Yutaka Yoshida,Tasuku Urita,Ryoji Kato